UCB is a global biopharmaceutical company with the ambition to transform the lives of people living with severe diseases. We focus on neurology and immunology disorders – putting patients at the center of our world.
UCB is continuously working to advance science and embrace new knowledge. We are leveraging scientific advances and skills in areas such as genetics, biomarkers and human biology. Patients inspire us to bring them value through cutting-edge science, innovative drugs, and practical solutions – so that they and their carers can get on with their lives.
UCB is employing around 7,500 people in all four corners of the globe, inspired by patients and driven by science.
Main tasks in the project
- WP2 – co Lead. UCB will contribute by providing strong expertise in development in Parkinson’s Disease.
- WP3 – UCB will contribute by providing biosensing expertise in hardware, algorithms and data management as well as implementation of device support and knowledge centre and participation in Task Force for Technology Integration.
- WP4 – UCB will contribute by providing expertise in data analysis.
- WP8 – UCB will contribute by providing strong regulatory expertise in devices and Parkinson regulatory requirements.